PKC-β is not necessary for cardiac hypertrophy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 5 49-5, 2001, Pages

  Roman, Brian B ^a   Geenen, David L ^a   Leitges, Michael ^b   Buttrick, Peter M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

Cell signaling; LacZ; Transgenic mouse

Indexed keywords

MESSENGER RNA; PROTEIN KINASE C;

ADAPTATION; ANIMAL MODEL; ARTICLE; HEART HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; HEMODYNAMIC PARAMETERS; KNOCKOUT MOUSE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0035025995     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.5.h2264     Document Type: Article

References (27)

1. Arckens L, Zhang F, Vanduffel W, Mailleux P, Vanderhaeghen JJ, Orban GA, and Vandesande F. Localization of the two protein kinase C β-mRNA subtypes in cat visual system. J Chem Neuroanat 8: 117-124, 1995.
2. Bartunek J, Weinberg EO, Tajima M, Rohrbach S, and Lorell BH. Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts. Circulation 99: 22-25, 1999.
3. 2+-sensitive isoforms in the failing human heart (comments). Circulation 99: 384-391, 1999.
4. Bowman JC, Steinberg SF, Jiang T, Geenen DL, Fishman GI, and Buttrick PM. Expression of protein kinase C-β in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest 100: 2189-2195, 1997.
5. Brandon NJ, Uren JM, Kittler JT, Wang H, Olsen R, Parker PJ, and Moss SJ. Subunit-specific association of protein kinase C and the receptor for activated C kinase with GABA type A receptors. J Neurosci 19: 9228-9234, 1999.
6. Clement O, Puceat M, Walsh MP, and Vassort G. Protein kinase C enhances myosin light-chain kinase effects on force development and ATPase activity in rat single skinned cardiac cells. Biochem J 285: 311-317, 1992.
7. Clerk A, Marie A, Bogoyevitch SJ, Fuller AL, Parker PJ, and Sugden PH. Expression of protein kinase C isoforms during cardiac ventricular development. Am J Physiol Heart Circ Physiol 269: H1087-H1097, 1995.
8. Eckhart AD, Duncan SJ, Penn RB, Benovic JL, Lefkowitz RJ, and Koch WJ. Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart. Circ Res 86: 43-50, 2000.
9. Gallicano GI, Yousef MC, and Capco DG. PKC: a pivotal regulator of early development. Bioessays 19: 29-36, 1997.
10. Hatae J and Kawata H. Participation of PKC in modulation of the excitation-contraction process of chick embryo cardiac muscle. Jpn J Physiol 47: 377-383, 1997.
11. 2+-independent contraction in vascular smooth muscle. Am J Physiol Cell Physiol 271: C589-C594, 1996.
12. Jalili T, Takeishi Y, Song G, Ball NA, Howles G, and Walsh RA. PKC translocation without changes in Galphaq and PLC-β protein abundance in cardiac hypertrophy and failure. Am J Physiol Heart Circ Physiol 277: H2298-H2304, 1999.
13. Johnson JA, Gray MO, Chen CH, and Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 271: 24962-24966, 1996.
14. Komachi H, Yanagisawa K, Shirasaki Y, and Miyatake T. Reduced membrane-associated protein kinase C-β immunoreactivity in the hippocampus of reserpinized rat brain. Neurosci Lett 149: 6-8, 1993.
15. Koya D and King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998.
16. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, and Tarakhovsky A. Immunodeficiency in protein kinase C-β-deficient mice. Science 273: 788-791, 1996.
17. Mackler SA, Brooks BP, and Eberwine JH. Stimulus-induced coordinate changes in mRNA abundance in single postsynaptic hippocampal CA1 neurons. Neuron 9: 539-548, 1992.
18. McKinsey TA and Olson EN. Cardiac hypertrophy: sorting out the circuitry. Curr Opin Genet Dev 9: 267-274, 1999.
19. Numann R, Hauschka SD, Catterall WA, and Scheuer T. Modulation of skeletal muscle sodium channels in a satellite cell line by protein kinase C. J Neurosci 14: 4226-4236, 1994.
20. Pasquet A. Differential expression of four protein kinase C isoforms in the murine ventricle during development (Abstract P140). American Heart Association Scientific Conference on Molecular, Cellular, and Integrated Physiological Approaches to the Failing Heart, Salt Lake City, UT, 1999.
21. Rockman HA, Ono S, Ross RS, Jones LR, Karimi M, Bhargava V, Ross J Jr, and Chien KR. Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci USA 91: 2694-2698, 1994.
22. Simpson PC. β-protein kinase C and hypertrophic signaling in human heart failure (Editorial). Circulation 99: 334-337, 1999.
23. Slawson SE, Roman BB, Williams DS, and Koretsky AP. Cardiac MRI of the normal and hypertrophied mouse heart. Magn Reson Med 39: 980-987, 1998.
24. Takeishi Y, Chu G, Kirkpatrick DM, Li Z, Wakasaki H, Kranias EG, King GL, and Walsh RA. In vivo phosphorylation of cardiac troponin I by protein kinase C-β2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest 102: 72-78, 1998.
25. Tian R, Miao W, Spindler M, Javadpour MM, McKinney R, Bowman JC, Buttrick PM, and Ingwall JS. Long-term expression of protein kinase C in adult mouse hearts improves postischemic recovery. Proc Natl Acad Sci USA 96: 13536-13541, 1999.
26. Wakasaki H, Koya D, Schoen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, and King GL. Targeted overexpression of protein kinase C-β2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci USA 94: 9320-9325, 1997.
27. i proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy. J Biol Chern 274: 9760-9770, 1999.